These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

520 related items for PubMed ID: 19531065

  • 1. Differential effects of EGFR ligands on endocytic sorting of the receptor.
    Roepstorff K, Grandal MV, Henriksen L, Knudsen SL, Lerdrup M, Grøvdal L, Willumsen BM, van Deurs B.
    Traffic; 2009 Aug; 10(8):1115-27. PubMed ID: 19531065
    [Abstract] [Full Text] [Related]

  • 2. Essential role of c-Cbl in amphiregulin-induced recycling and signaling of the endogenous epidermal growth factor receptor.
    Baldys A, Göoz M, Morinelli TA, Lee MH, Raymond JR, Luttrell LM, Raymond JR.
    Biochemistry; 2009 Feb 24; 48(7):1462-73. PubMed ID: 19173594
    [Abstract] [Full Text] [Related]

  • 3. Metastasis suppressor tetraspanin CD82/KAI1 regulates ubiquitylation of epidermal growth factor receptor.
    Odintsova E, van Niel G, Conjeaud H, Raposo G, Iwamoto R, Mekada E, Berditchevski F.
    J Biol Chem; 2013 Sep 06; 288(36):26323-26334. PubMed ID: 23897813
    [Abstract] [Full Text] [Related]

  • 4. EGF and amphiregulin differentially regulate Cbl recruitment to endosomes and EGF receptor fate.
    Stern KA, Place TL, Lill NL.
    Biochem J; 2008 Mar 15; 410(3):585-94. PubMed ID: 18045238
    [Abstract] [Full Text] [Related]

  • 5. The epidermal growth factor receptor couples transforming growth factor-alpha, heparin-binding epidermal growth factor-like factor, and amphiregulin to Neu, ErbB-3, and ErbB-4.
    Riese DJ, Kim ED, Elenius K, Buckley S, Klagsbrun M, Plowman GD, Stern DF.
    J Biol Chem; 1996 Aug 16; 271(33):20047-52. PubMed ID: 8702723
    [Abstract] [Full Text] [Related]

  • 6. Internalization mechanisms of the epidermal growth factor receptor after activation with different ligands.
    Henriksen L, Grandal MV, Knudsen SL, van Deurs B, Grøvdal LM.
    PLoS One; 2013 Aug 16; 8(3):e58148. PubMed ID: 23472148
    [Abstract] [Full Text] [Related]

  • 7. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
    Sahin U, Weskamp G, Kelly K, Zhou HM, Higashiyama S, Peschon J, Hartmann D, Saftig P, Blobel CP.
    J Cell Biol; 2004 Mar 01; 164(5):769-79. PubMed ID: 14993236
    [Abstract] [Full Text] [Related]

  • 8. Ligand-induced lysosomal epidermal growth factor receptor (EGFR) degradation is preceded by proteasome-dependent EGFR de-ubiquitination.
    Alwan HA, van Zoelen EJ, van Leeuwen JE.
    J Biol Chem; 2003 Sep 12; 278(37):35781-90. PubMed ID: 12829707
    [Abstract] [Full Text] [Related]

  • 9. Substrate selectivity of epidermal growth factor-receptor ligand sheddases and their regulation by phorbol esters and calcium influx.
    Horiuchi K, Le Gall S, Schulte M, Yamaguchi T, Reiss K, Murphy G, Toyama Y, Hartmann D, Saftig P, Blobel CP.
    Mol Biol Cell; 2007 Jan 12; 18(1):176-88. PubMed ID: 17079736
    [Abstract] [Full Text] [Related]

  • 10. The DNA damaging agent VP16 induces the expression of a subset of ligands from the EGF system in bladder cancer cells, whereas none of the four EGF receptors are induced.
    Sørensen BS, Tørring N, Bor MV, Nexø E.
    Mol Cell Biochem; 2004 May 12; 260(1-2):129-35. PubMed ID: 15228094
    [Abstract] [Full Text] [Related]

  • 11. Activation of epidermal growth factor receptor signaling by the prostaglandin E(2) receptor EP4 pathway during gastric tumorigenesis.
    Oshima H, Popivanova BK, Oguma K, Kong D, Ishikawa TO, Oshima M.
    Cancer Sci; 2011 Apr 12; 102(4):713-9. PubMed ID: 21205091
    [Abstract] [Full Text] [Related]

  • 12. Anti-EGFR monoclonal antibodies which act as EGF, TGF alpha, HB-EGF and BTC antagonists block the binding of epiregulin to EGFR-expressing tumours.
    Modjtahedi H, Komurasaki T, Toyoda H, Dean C.
    Int J Cancer; 1998 Jan 19; 75(2):310-6. PubMed ID: 9462724
    [Abstract] [Full Text] [Related]

  • 13. EGFR ligands exhibit functional differences in models of paracrine and autocrine signaling.
    Wilson KJ, Mill C, Lambert S, Buchman J, Wilson TR, Hernandez-Gordillo V, Gallo RM, Ades LM, Settleman J, Riese DJ.
    Growth Factors; 2012 Apr 19; 30(2):107-16. PubMed ID: 22260327
    [Abstract] [Full Text] [Related]

  • 14. Selective roles for tumor necrosis factor alpha-converting enzyme/ADAM17 in the shedding of the epidermal growth factor receptor ligand family: the juxtamembrane stalk determines cleavage efficiency.
    Hinkle CL, Sunnarborg SW, Loiselle D, Parker CE, Stevenson M, Russell WE, Lee DC.
    J Biol Chem; 2004 Jun 04; 279(23):24179-88. PubMed ID: 15066986
    [Abstract] [Full Text] [Related]

  • 15. Effects of different ligands on epidermal growth factor receptor (EGFR) nuclear translocation.
    Faria JAQA, de Andrade C, Goes AM, Rodrigues MA, Gomes DA.
    Biochem Biophys Res Commun; 2016 Sep 09; 478(1):39-45. PubMed ID: 27462018
    [Abstract] [Full Text] [Related]

  • 16. ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis.
    Révillion F, Lhotellier V, Hornez L, Bonneterre J, Peyrat JP.
    Ann Oncol; 2008 Jan 09; 19(1):73-80. PubMed ID: 17962208
    [Abstract] [Full Text] [Related]

  • 17. Amphiregulin exosomes increase cancer cell invasion.
    Higginbotham JN, Demory Beckler M, Gephart JD, Franklin JL, Bogatcheva G, Kremers GJ, Piston DW, Ayers GD, McConnell RE, Tyska MJ, Coffey RJ.
    Curr Biol; 2011 May 10; 21(9):779-86. PubMed ID: 21514161
    [Abstract] [Full Text] [Related]

  • 18. ErbB2 expression increases the spectrum and potency of ligand-mediated signal transduction through ErbB4.
    Wang LM, Kuo A, Alimandi M, Veri MC, Lee CC, Kapoor V, Ellmore N, Chen XH, Pierce JH.
    Proc Natl Acad Sci U S A; 1998 Jun 09; 95(12):6809-14. PubMed ID: 9618494
    [Abstract] [Full Text] [Related]

  • 19. Differential ErbB1 signaling in squamous cell versus basal cell carcinoma of the skin.
    Rittié L, Kansra S, Stoll SW, Li Y, Gudjonsson JE, Shao Y, Michael LE, Fisher GJ, Johnson TM, Elder JT.
    Am J Pathol; 2007 Jun 09; 170(6):2089-99. PubMed ID: 17525275
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of heparin-binding epidermal growth factor-like growth factor and a disintegrin and metalloprotease 17 expression in human ovarian cancer.
    Tanaka Y, Miyamoto S, Suzuki SO, Oki E, Yagi H, Sonoda K, Yamazaki A, Mizushima H, Maehara Y, Mekada E, Nakano H.
    Clin Cancer Res; 2005 Jul 01; 11(13):4783-92. PubMed ID: 16000575
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.